GB0002691D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB0002691D0 GB0002691D0 GBGB0002691.4A GB0002691A GB0002691D0 GB 0002691 D0 GB0002691 D0 GB 0002691D0 GB 0002691 A GB0002691 A GB 0002691A GB 0002691 D0 GB0002691 D0 GB 0002691D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (36)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0002691A GB2358799A (en) | 2000-02-04 | 2000-02-04 | A pharmaceutical composition comprising pemetrexed and an antioxidant |
| JP2001556474A JP2003521518A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrex together with monothioglycerol, L-cysteine or thioglycolic acid |
| AU34422/01A AU3442201A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| EP01906523A EP1265612B1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| CZ20022654A CZ20022654A3 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition containing Pemetrexed along with monothioglycerol, L-cysteine or thioglycolic acid |
| US10/181,379 US6686365B2 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition |
| MXPA02007191A MXPA02007191A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l cystein or thioglycolic acid. |
| UA2002086475A UA72578C2 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed in combination with monothioglycerol, l-cysteine or thioglycolic acid |
| HR20020636A HRP20020636A2 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed with monothioglycerol l-cystein or thioglycolic acid |
| AT01906523T ATE267601T1 (en) | 2000-02-04 | 2001-01-23 | PHARMACEUTICAL COMPOSITION CONTAINING PEMETREXED TOGETHER WITH MONOTHIOGLYCEROL, L-CYSTEINE OR THIOGLYCOLIC ACID |
| CN01804441A CN1396828A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid |
| EA200200831A EA004708B1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| BR0107958-1A BR0107958A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition containing pemetrexate together with l-cysteine monotrioglycerol or thioglycolic acid |
| IL15047501A IL150475A0 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| PL01356705A PL356705A1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| DK01906523T DK1265612T3 (en) | 2000-02-04 | 2001-01-23 | A pharmaceutical composition comprising pemetrexed and monothioglycerol, l-cysteine or thioglycolic acid |
| NZ519727A NZ519727A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol L-cysteine or thioglycolic acid |
| DE60103512T DE60103512T2 (en) | 2000-02-04 | 2001-01-23 | PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED WITH MONOTHIOGLYCEROL, L-CYSTEIN OR THIOGLYCOLIC ACID |
| CA002399124A CA2399124A1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| HK03103377.4A HK1052461B (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| KR1020027009930A KR20020081293A (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical Composition Comprising Pemetrexed Together With Monothioglycerol L-Cystein or Thioglycolic Acid |
| HU0300709A HUP0300709A3 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothiaglycerol l-cystein or thioglycolic acid |
| SI200130113T SI1265612T1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| SK1098-2002A SK10982002A3 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol L-cystein or thioglycolic acid |
| TR2004/01436T TR200401436T4 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition containing pemetrexed with monothioglycerol, L-system or thioglycolic acid |
| DZ013269A DZ3269A1 (en) | 2000-02-04 | 2001-01-23 | PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED WITH MONOTHIOGLYCEROL, CYSTEIN L OR THIOGLYCOLIC ACID |
| ES01906523T ES2220716T3 (en) | 2000-02-04 | 2001-01-23 | PHARMACEUTICAL COMPOSITION THAT INCLUDES PEMETREXED WITH MONOTIOGLYCEROL, L-CYSTEINE AND THIOGLYCOLIC ACID. |
| PT01906523T PT1265612E (en) | 2000-02-04 | 2001-01-23 | PHARMACEUTICAL COMPOSITION UNDERSTANDING PEMETREXED CONVENIENTLY WITH MONOTIOGLICEROL L-CYSTEIN OR THYROGLYCOLIC ACID |
| PCT/US2001/000648 WO2001056575A1 (en) | 2000-02-04 | 2001-01-23 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid |
| MYPI20010433A MY129450A (en) | 2000-02-04 | 2001-01-31 | Pharmaceutical composition |
| PE2001000116A PE20011223A1 (en) | 2000-02-04 | 2001-02-01 | PHARMACEUTICAL COMPOSITION INCLUDING PEMETREXED AND AN ANTIOXIDANT SUCH AS MONOTHIOGLYCEROL, L-CYSTEINE AND THIOGLICOLIC ACID |
| CO01007346A CO5280222A1 (en) | 2000-02-04 | 2001-02-01 | PHARMACEUTICAL COMPOSITION THAT PEMETREXED INCLUDES |
| ARP010100507A AR027360A1 (en) | 2000-02-04 | 2001-02-02 | PHARMACEUTICAL COMPOSITION |
| SV2001000301A SV2002000301A (en) | 2000-02-04 | 2001-02-02 | PHARMACEUTICAL COMPOSITION REF. Z-1032 |
| ZA200205112A ZA200205112B (en) | 2000-02-04 | 2002-06-25 | Pharmaceutical composition comprising pemetrexed together with monothioglycerol L-cystein or thioglycolic acid. |
| NO20023379A NO20023379L (en) | 2000-02-04 | 2002-07-12 | A pharmaceutical composition comprising premetrexed together with monothioglycerol L-cysteine or thioglycolic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0002691A GB2358799A (en) | 2000-02-04 | 2000-02-04 | A pharmaceutical composition comprising pemetrexed and an antioxidant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0002691D0 true GB0002691D0 (en) | 2000-03-29 |
| GB2358799A GB2358799A (en) | 2001-08-08 |
Family
ID=9885044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0002691A Withdrawn GB2358799A (en) | 2000-02-04 | 2000-02-04 | A pharmaceutical composition comprising pemetrexed and an antioxidant |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB2358799A (en) |
| UA (1) | UA72578C2 (en) |
| ZA (1) | ZA200205112B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2666463A1 (en) * | 2012-05-21 | 2013-11-27 | Synthon BV | Stabilized liquid composition comprising pemetrexed |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4895946A (en) * | 1987-10-26 | 1990-01-23 | The Trustees Of Princeton University | Process for the preparation of fused pyridine compounds |
-
2000
- 2000-02-04 GB GB0002691A patent/GB2358799A/en not_active Withdrawn
-
2001
- 2001-01-23 UA UA2002086475A patent/UA72578C2/en unknown
-
2002
- 2002-06-25 ZA ZA200205112A patent/ZA200205112B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200205112B (en) | 2003-11-26 |
| GB2358799A (en) | 2001-08-08 |
| UA72578C2 (en) | 2005-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24357A (en) | New Pharmaceutical composition | |
| IL152659A0 (en) | Pharmaceutical composition | |
| GB2358583B (en) | Pharmaceutical compositions | |
| SI1524266T1 (en) | Pharmaceutical composition | |
| HUP0204555A3 (en) | Pharmaceutical composition | |
| HUP0300582A3 (en) | Pharmaceutical compositions | |
| AU6219601A (en) | Pharmaceutical compositions | |
| GB0006133D0 (en) | Novel pharmaceutical | |
| GB0009584D0 (en) | Pharmaceutical compositions | |
| AU8576801A (en) | Pharmaceutical compositions | |
| HUP0400553A3 (en) | Pharmaceutical compositions | |
| IL154238A0 (en) | Pharmaceutical composition | |
| GB0008485D0 (en) | Pharmaceutical compositions | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| AU8254101A (en) | Medicinal compositions | |
| GB0002691D0 (en) | Pharmaceutical composition | |
| GB0101094D0 (en) | Pharmaceutical composition | |
| GB0026716D0 (en) | Pharmaceutical composition | |
| GB0006301D0 (en) | Pharmaceutical composition | |
| GB0027375D0 (en) | Pharmaceutical composition | |
| GB0016684D0 (en) | Pharmaceutical composition | |
| GB0019599D0 (en) | Pharmaceutical composition | |
| GB0008872D0 (en) | Pharmaceutical compositions | |
| HU0700204D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |